Clinical Trial Update: Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI) [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluated sublingual tizanidine in children with chronic traumatic brain injury; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• TIZANIDINE (TIZANIDINE)

Snippet

Sponsor: Teva GTC | Conditions: Traumatic Brain Injury | Phase 1 | Status: COMPLETED